Oryon Cell Therapies ("Oryon"), a clinical-stage biotechnology company focused on developing autologous neuron replacement medicines for Parkinson's disease and other neurodegenerative disorders, ...
Hope Biosciences has linked its stem cell therapy candidate to improved motor function in Parkinson’s disease patients in a phase 2 trial. The single-site study randomized 60 people with early to ...
Learn how to stay active if you have advanced Parkinson’s, with safe exercises that improve mobility, mood, and sleep.
TOPEKA, Kan. (WIBW) -Washburn University students learned a specialized technique Tuesday to help people with Parkinson’s disease, a condition affecting around 1 million Americans. Parkinson’s disease ...
Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell therapy in ...